Experimental study on ultrasound-guided intratumoral injection of "Star-99" in treatment of hepatocellular carcinoma of nude mice

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 701-705

  Lin, Li Wu ^a   Lin, Xiao Dong ^a   He, Yi Mi ^a   Gao, Shang Da ^a   Xue, En Sheng ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHINESE DRUG; INTERLEUKIN 2; SODIUM CHLORIDE; STAR 99; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER TRANSPLANTATION; CELLULAR IMMUNITY; CHINESE MEDICINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; ECHOGRAPHY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INHIBITION KINETICS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0038300218     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.701     Document Type: Article

References (42)

1. Lin LW, Ye Z, Xue ES, Gao SD, He YM. A study of percutaneous hepatic quantified ethanol injection in treatment of hepatocarcinoma. Zhongguo Chaosheng Yixue Zazhi 2000; 16: 514-516
2. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Amada R. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. Hepatology 2000; 32: 1224-1229
3. Livraghi T, Benedini V, Lazzaroni S, Meloni F, Torzilli G, Vettori C. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998; 83: 48-57
4. Tian G, Yu JP, Luo HS, Yu BP, Yue H, Li JY, Mei Q. Effect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells. World J Gastroenterol 2002; 8: 483-487
5. Li J, Wang WL, Wang WY, Liu B, Wang BY. Apoptosis in human hepatocellular carcinoma by terminal deoxynucleotidyl transferase-mediate. Huaren Xiaohua Zazhi 1998; 6: 491-494
6. Wang LS, Pan LJ, Li MS, Sun Y, Shi L, Zhang YL, Zhou DY. Apoptosis of large bowel carcinoma induced by complete peptide polyose. Shijie Huaren Xiaohua Zazhi 1999; 7: 710
7. Zhang Z, Yuan Y, Gao H, Dong M, Wu HQ, Wang L, Wang MX. In situ observation of apoptosis and proliferation in gastric cancer and precanceration. Shijie Huaren Xiaohua Zazhi 1999; 7: 802-803
8. Pacella CM, Bizzarri G, Magnolfi F, Cecconi P, Caspani B, Anelli V, Bianchini A, Valle D, Pacella S, Manenti G, Rossi Z. Laser thermal ablation in the treatment of small hepatocellular carcinoma: Results in 74 patients. Radiology 2001; 221: 712-720
9. Pacella CM, Bizzarri G, Magnolfi F, Cecconi P, Caspani B, Anelli V, Bianchini A, Valle D, Pacella S, Manenti G, Rossi Z. Hepatocellular carcinoma: Long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001; 219: 669-678
10. Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang LJ, Huang JF. Hepatocellular carcinoma: Us-guided percutaneous microwave coagulation therapy. Radiology 2001; 221: 167-172
11. Ishida T, Murakami T, Shibata T, Inoue Y, Takamura M, Niinobu T, Sato T, Nakamura H. Percutaneous microwave tumor coagulation for hepatocellular carcinomas with interruption of segmental hepatic blood flow. J Vasc Interv Radiol 2002; 13: 185-191
12. Dick EA, Taylor-Robinson SD, Thomas HC, Gedroyc WMW. Ablative therapy for liver tumours. Gut 2002; 50: 733-739
13. Matsuda M, Fujii H, Kono H, Matsumoto Y. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: Repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg 2001; 8: 353-359
14. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000; 217: 633-646
15. Ahmed M, Lobo SM, Weinstein J, Kruskal JB, Gazelle GS, Halpern EF, Afzal SK, Lenkinski RE, Goldberg SN. Improved coagulation with saline solution pretreatment during radiofrequency tumor ablation in a canine model. J Vasc Interv Radiol 2002; 13: 717-724
16. Choi D, Lim HK, Kim SH, Lee WJ, Jang HJ, Kim H, Lee SJ, Lim JH. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: Comparison of multiphase helical computed tomography and power doppler ultrasonography with a microbubble contrast agent. J Ultrasound Med 2002; 21: 391-401
17. Giorgio A, Francica G, Tarantino L, De Stefano G. Radio-frequency ablation of hepatocellular carcinoma lesions. Radiology 2001; 218: 918-919
18. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: Challenges and opportunities-part II. J Vasc Interv Radiol 2001; 12: 1135-1148
19. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS. Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions. Radiology 2000; 214: 761-768
20. Mc Dannold NJ, Jolesz FA, Hynynen KH. Determination of the optimal delay between sonications during focused ultrasound surgery in rabbits by using MR imaging to monitor thermal buildup in vivo. Radiology 1999; 211: 419-426
21. Wu F, Chen WZ, Bai J. Effect of high-intensity focused ultrasound on the patients with hepatocellular carcinoma: Preliminary report. Zhonghua Chaosheng Yingxiangxue Zazhi 1999; 8: 213-216
22. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H, Kosuge T. Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34: 707-713
23. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524
24. Morimoto M, Sugimori K, Shirato K, Kokawa A, Tomita N, Saito T, Tanaka N, Nozawa A, Hara M, Sekihara H, Shimada H, Imada T, Tanaka K. Treatment of hepatocellular carcinoma with radiofrequency ablation: Radiologic-histologic correlation during follow-up periods. Hepatology 2002; 35: 1467-1475
25. Parslow TG, Stites DP, Terr AI, Imboden JB. Medical Immunology. Beijing Science Press 2002; 154-156
26. Lin LW, He YM, Gao SD, Yan FD. Percutaneous intratumoral injection of chinese traditional medicine "Star-99" in treatment of hepatic carcinoma: An experimental study. Zhonghua Chaosheng Yingxiangxue Zazhi 2002; 11: 45-48
27. Kimura K, Bowen C, Spiegel S, Gelmann EP. Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis. Cancer Res 1999; 59: 1606-1414
28. Liang WJ, Huang ZY, Ding YQ, Zhang WD. Lovo cell line apoptosis induced by cycloheximide combined with TNFα. Shijie Huaren Xiaohua Zazhi 1999; 7: 326-328
29. Shen YF, Zhuang H, Shen JW, Chen SB. Cell apoptosis and neoplasms. Shijie Huaren Xiaohua Zazhi 1999; 7: 267-268
30. He SW, Shen KQ, He YJ, Xie B, Zhao YM. Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma. World J Gastroenterol 1999; 5: 408-416
31. Huang PL, Zhu SN, Lu SL, Dai SZ, Jin YL. Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells. World J Gastroenterol 2000; 6: 295-297
32. Li J, Wang WL, Liu B. Angiogenesis and apoptosis in human hepatocellular carcinoma. Huaren Xiaohua Zazhi 1998; 6: 1057-1060
33. Liu HF, Liu WW, Fang DC, Yang SM, Wang RQ. Bax gene expression and its relationship with apoptosis in human gastric carcinoma and precancerous lesions. Shijie Huaren Xiaohua Zazhi 2000; 8: 665-668
34. Tu SP, Jiang SH, Tan JH, Jiang XH, Qiao MM, Zhang YP, Wu YL, Wu YX. Proliferation inhibition and apoptosis induction by arsenic trioxide on gastric cancer cell SGC-7901. Shijie Huaren Xiaohua Zazhi 1999; 7: 18-21
35. Chen HY, Liu WH, Qin SK. Induction of arsenic trioxide on apoptosis of hepatocarcinoma cell lines. Shijie Huaren Xiaohua Zazhi 2000; 8: 532-535
36. Liu HF, Liu WW, Fang DC. Effect of combined anti-Fas mAb and IFN-γ on the induction of apoptosis in human gastric carcinoma cell line SGC-7901. Shijie Huaren Xiaohua Zazhi 2000; 8: 1316-1364
37. Sun BH, Zhao XP, Wang BJ, Yang DL, Hao LJ. FADD and TRADD expression and apoptosis in primary human hepatocellular carcinoma. World J Gastroenterol 2000; 6: 223-227
38. Sun ZX, Ma QW, Zhao TD, Wei YL, Wang GS, Li JS. Apoptosis induced by norcantharidin in human tumor cells. World J Gastroenterol 2000; 6: 263-265
39. Xue XC, Fang GE, Hua JD. Gastric cancer and apoptosis. Shijie Huaren Xiaohua Zazhi 1999; 7: 359-361
40. Cheng J, Huang HC. Programmed Cell Death and Disease. Peking Union Medical College Press 1997: 1-8
41. Brown JM, Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 1999; 59: 1391-1399
42. Ikeda M, Shomori K, Endo K, Makino T, Matsuura T, Ito H. Frequent occurrence of apoptosis is an early event in the oncogenesis of human gastric carcinoma. Virchows Arch 1998; 432; 43-47